54981-39-4

Basic information

• Product Name: Benzenesulfonic acid, 3-(acetylamino)-
• Synonyms: Benzenesulfonic acid,3-(acetylamino);N-Acetyl-metanilsaeure;Acetanilid-sulfonsaeure-(3);m-Acetaminobenzenesulfonic acid (N-acetylmetanilic acid);3-Acetamino-benzol-sulfonsaeure-(1);N-Acetyl-anilin-sulfonsaeure-(3);3-Acetylamino-benzolsulfonsaeure;3-acetylamino-benzenesulfonic acid
• CAS NO: 54981-39-4
• Molecular Formula: C8H9NO4S
• Molecular Weight: 215.23
• Mol File: 54981-39-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzenesulfonic acid, 3-(acetylamino)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonic acid, 3-(acetylamino)-(54981-39-4)
• EPA Substance Registry System: Benzenesulfonic acid, 3-(acetylamino)-(54981-39-4)

Safety Data

• Hazardous Substances Data: 54981-39-4(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 121-47-1 3-aminobenzenesulfonic acid 
• 75-36-5 acetyl chloride 

Downstream Products

• 1456900-15-4 3-acetamidobenzenesulfonyl azide 
• 952016-85-2 5-acetylamino-2-nitro-benzenesulfonic acid 
• 23905-47-7 bis-(3-acetylamino-phenyl)-disulfide 
• 23905-46-6 3-acetamidobenzene-1-sulfonyl chloride 

Relevant articles and documents

N - aryl sulfonamide compound, its pharmaceutical composition and its use (by machine translation)

The invention discloses a category represented by the following general formula I N - aryl sulfonamide compound, to the compound as the active ingredient of the pharmaceutical composition, and their preparation for treating Lp - PLA2 In the diseases related to the activity of the use. (by machine translation)

DISAZO COMPOUNDS AND THEIR USE IN INK-JET PRINTING

A compound of Formula (1) or asalt thereof: wherein: X is N or C(CN); Z is optionally substituted naphthyl;and Ar is an aryl group carrying at least one nitro substituentand optionally one or more further substituents. Also compositions, inks, printing processes, printed material and ink-jet cartridges.

SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE

The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.